Olympic Cannabis Ban To Be Re-Examined After Sha'Carri Richardson's Disqualification From Tokyo Games

The World Anti-Doping Agency (WADA) announced Tuesday that it intends to review the status of cannabis on its banned substance list, following last summer's exclusion of track star Sha’Carri Richardson from competing at the Tokyo Olympics after she tested positive for cannabis in her home state of Oregon, where marijuana is legal.

The scientific review will be conducted by a group that advises WADA in 2022.

“Following receipt of requests from a number of stakeholders, the (executive committee) endorsed the decision of the List Expert Advisory Group to initiate in 2022 a scientific review of the status of cannabis,” a WADA statement read. “Cannabis is currently prohibited in competition and will continue to be in 2022.”

Fastest Runner In The World

When Richardson tested positive for cannabis during the U.S. Olympic Track & Field Trials in June, she was given a one-month suspension that essentially wiped out her results - an extraordinary 10.86-second 100m dash - that had qualified her for a spot on the Olympic team.

Outcry Then And Now

The suspension sparked anger as well as an outpouring of support for Richardson among the cannabis industry and all sectors of society, including several members of Congress. Soon thereafter, rose a call for a review of cannabis' status from numerous organizations, including the White House via the U.S. Office of National Drug Control Policy (ONDCP), which told Benzinga at the time that it would "ask WADA to gather additional information on its cannabis policies." 

See also: Al Harrington's Viola, CSC Partner On Scholarship, Cannabis Course To Increase Equitable Access To Industry

Prior to the Tokyo Olympics in July, the White House was in pursuit of a meeting with WADA to discuss cannabis’ position as a banned substance, said the ONDCP press secretary.

A Little Science Please

One of the justifications for the suspension of Richardson, 21 - that cannabis was potentially performance-enhancing - was roundly rejected by scientists. 

“It is so ironic that now they are using that argument when in fact all these years there has been been very little scientific research done about the benefits of cannabis,” Dr. Peter Grinspoon, Harvard Medical School instructor and cannabis expert, told Benzinga at the time. “Cannabis research was essentially prohibited so no one really knows where the US Anti-Doping Agency came up with these standards. Cannabis meets none of them.”

See also: Dr. Peter Grinspoon From Harvard University On Oxycodone And Cannabis For Harm Reduction

Encuentra nuestro contenido en Español en El Planteo:

Photo by Nicolas Hoizey on Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisGovernmentNewsRegulationsSportsMarketsGeneralOlympic gamesPeter GrinspoonSha'Carri Richardson
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!